Patents Assigned to Genomic Vision
-
Publication number: 20180150597Abstract: Methods including in-silico steps for design and synthesis of Genomic Morse Code (“GMC”) probes including design of combinations of polynucleotide sequences and labelling colors for analysis of large rearrangements in targeted genetic regions as well as allele characterization of complex regions and localization of events such as replication, DNA reparation or epigenetics in particular regions. Color-encoded sets of probes that produce characteristic or unique color patterns when painted on a target nucleic acid sequence. Methods for using color-encoded sets of probes.Type: ApplicationFiled: November 29, 2017Publication date: May 31, 2018Applicant: Genomic Vision SAInventors: Sara Berthoumieux, Yannick Fourne, Jun Komatsu, Frederic Fer, Aaron Bensimon
-
Publication number: 20160047006Abstract: A method for detecting in vitro the presence of a genome of a DNA virus or a viral derived DNA in an infected eukaryotic cell, tissue or biological fluid using Molecular Combing or other nucleic acid stretching methods together with probes, especially nucleic acid probes, having a special design. A method for monitoring in vitro the effects of anti-viral treatment by following the presence of genomic viral or viral derived DNA polynucleotides in a virus-infected cell, tissue or biological fluid. Detection of an infectious form of a virus using Molecular Combing and DNA hybridization. A kit comprising probes used to carry out these methods and a composition comprising the probes.Type: ApplicationFiled: March 4, 2015Publication date: February 18, 2016Applicant: Genomic VisionInventors: Charlotte MAHIET, Fabrice Salvaire, Emmanuel Conseiller, Sebastien Barradeau
-
Publication number: 20160032405Abstract: A method for detection, visualization and/or comparison of polynucleotide sequences of interest using specially designed sets of long and short probes that enhance resolution and simplify visualization and detection. Probe compositions useful for practicing this method and procedures for identifying useful probes and probe combinations. These methods are useful for the detection of genomic rearrangements, especially those associated with various diseases, disorders and conditions including cancer or for assessment of genomic rearrangements associated with therapy. The probe compositions may be used in kits for detection of genetic rearrangements or in companion diagnostic products or kits, such as kits for the diagnosis or assessment of predisposition to cancer such as colorectal cancer.Type: ApplicationFiled: August 3, 2015Publication date: February 4, 2016Applicant: Genomic VisionInventors: Jun KOMATSU, Pierre Walrafen, Maurizio Ceppi, Emmanuel Conseiller
-
Patent number: 8586723Abstract: The present invention relates to a method of detection of the presence of at least one domain of interest on a macromolecule to test, wherein said method comprises the following steps: a) determining beforehand at least two target regions on the domain of interest, designing and obtaining corresponding labeled probes of each target region, named set of probe of the domain of interest, the position of these probes one compared to the others being chosen and forming the specific signature of said domain of interest on the macromolecule to test; b) after spreading of the macromolecule to test on which the probes obtained in step a) are bound, detection of the position one compared to the others of the probes bound on the linearized macromolecule, the detection of the signature of a domain of interest indicating the presence of said domain of interest on the macromolecule to test, and conversely the absence of detection of signature or part of signature of a domain of interest indicating the absence of said domaiType: GrantFiled: September 5, 2007Date of Patent: November 19, 2013Assignees: Institut Pasteur, Genomic VisionInventors: Ronald Lebofsky, Aaron Bensimon, Pierre Walrafen
-
Publication number: 20130084564Abstract: Polynucleotides useful for detecting copy number variation of RNU2 sequences and methods of assessing risk of developing breast or ovarian cancer using molecular combing and/or detection or quantification of BRCA1 expression.Type: ApplicationFiled: June 1, 2012Publication date: April 4, 2013Applicants: Genomic Vision, Centre Leon Berard, Universite Claude Bernard Lyon 1, Centre National de la Recherche ScientifiqueInventors: Sylvie Mazoyer, Chloe Tessereau, Maurizio Ceppi, Kevin Cheeseman
-
Patent number: 8103122Abstract: A method of detecting a curvilinear object of a noisy image. The method includes filtering the noisy image in accordance with a two dimensional line profile. The line profile is selected within a class of steerable filters. A beamlet coefficient is calculated in accordance with the filtering, wherein a coefficient above a predetermined threshold identifies a local feature.Type: GrantFiled: April 14, 2008Date of Patent: January 24, 2012Assignees: Institut Pasteur, Genomic VisionInventors: Aaron Bensimon, Jean-Christophe Olivo-Marin, Sylvain Berlemont
-
Patent number: 7985542Abstract: The present invention relates to a method of detection of the presence of at least one domain of interest on a macromolecule to test, wherein said method comprises the following steps: a) determining beforehand at least two target regions on the domain of interest, designing and obtaining corresponding labeled probes of each target region, named set of probe of the domain of interest, the position of these probes one compared to the others being chosen and forming the specific signature of said domain of interest on the macromolecule to test; b) after spreading of the macromolecule to test on which the probes obtained in step a) are bound, detection of the position one compared to the others of the probes bound on the linearized macromolecule, the detection of the signature of a domain of interest indicating the presence of said domain of interest on the macromolecule to test, and conversely the absence of detection of signature or part of signature of a domain of interest indicating the absence of said doType: GrantFiled: September 7, 2006Date of Patent: July 26, 2011Assignees: Institut Pasteur, Genomic VisionInventors: Ronald Lebofsky, Aaron Bensimon, Pierre Walrafen